Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis

Detalhes bibliográficos
Autor(a) principal: Santiago-Silva, Kaio Maciel de
Data de Publicação: 2022
Outros Autores: Bortoleti, Bruna Taciane da Silva, Oliveira, Laudicéa do Nascimento, Maia, Fernanda Lima de Azevedo, Castro, Joyce Cristina, Costa, Ivete Conchon, Lazarin, Danielle Bidóia, Wardell, James L., Wardell, Solange M. S. V., Albuquerque, Magaly Girão, Lima, Camilo Henrique da Silva, Pavanelli, Wander Rogério, Bispo, Marcelle de Lima Ferreira, Gonçalves, Raoni Schroeder B.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/56069
Resumo: Universidade Estadual de Londrina. Centro de Ciências Exatas. Departamento de Química. Laboratório de Síntese de Moléculas Medicinais. Londrina, PR, Brasil.
id CRUZ_f3f50da0617bac12798c73cee69b8c9f
oai_identifier_str oai:www.arca.fiocruz.br:icict/56069
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Santiago-Silva, Kaio Maciel deBortoleti, Bruna Taciane da SilvaOliveira, Laudicéa do NascimentoMaia, Fernanda Lima de AzevedoCastro, Joyce CristinaCosta, Ivete ConchonLazarin, Danielle BidóiaWardell, James L.Wardell, Solange M. S. V.Albuquerque, Magaly GirãoLima, Camilo Henrique da SilvaPavanelli, Wander RogérioBispo, Marcelle de Lima FerreiraGonçalves, Raoni Schroeder B.2022-12-19T16:12:10Z2022-12-19T16:12:10Z2022SANTIAGO-SILVA, Kaio Maciel de et al. Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis. Antibiotics, v. 11, n. 1402, p. 1–23, 2022.2079-6382https://www.arca.fiocruz.br/handle/icict/56069porMDPI4,8-dimethoxynaphthalenylLeishmaniasisNeglected DiseasesTrypanosomatidsTrypanothione reductaseArginasaEnfermedades DesatendidasMaladies négligéesArginaseLeishmanioseDoenças NegligenciadasAntileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Estadual de Londrina. Centro de Ciências Exatas. Departamento de Química. Laboratório de Síntese de Moléculas Medicinais. Londrina, PR, Brasil.Universidade Estadual de Londrina. Centro de Ciências Biológicas. Departamento de Ciências Patológicas. Laboratório de Imunoparasitologia de Doenças Negligenciadas e Câncer. Londrina, PR, Brasil. / Fundação Oswaldo Cruz. Instituto Carlos Chagas. Programa de Pós-Graduação em Biociências e Biotecnologia. Curitiba, PR, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Universidade Estadual de Londrina. Centro de Ciências Biológicas. Departamento de Ciências Patológicas. Laboratório de Imunoparasitologia de Doenças Negligenciadas e Câncer. Londrina, PR, Brasil.Universidade Estadual de Londrina. Centro de Ciências Biológicas. Departamento de Ciências Patológicas. Laboratório de Imunoparasitologia de Doenças Negligenciadas e Câncer. Londrina, PR, Brasil.Department of Chemistry. University of Aberdeen. Aberdeen, Scotland, UK.CHEMSOL. Aberdeen, Scotland, UK.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Universidade Estadual de Londrina. Centro de Ciências Biológicas. Departamento de Ciências Patológicas. Laboratório de Imunoparasitologia de Doenças Negligenciadas e Câncer. Londrina, PR, Brasil.Universidade Estadual de Londrina. Centro de Ciências Exatas. Departamento de Química. Laboratório de Síntese de Moléculas Medicinais. Londrina, PR, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Química. Rio de Janeiro, RJ, Brasil.Leishmaniasis is a neglected tropical disease caused by Leishmania species. Available therapeutic options have several limitations. The drive to develop new, more potent, and selective antileishmanial agents is thus a major goal. Herein we report the synthesis and the biological activity evaluation against promastigote and amastigote forms of Leishmania amazonensis of nine 4,8-dimethoxynaphthalenyl chalcones. Compound ((E)-1-(4,8-dimethoxynaphthalen-1-yl)-3-(4- nitrophenyl)prop-2-en-1-one), 4f, was the most promising with an IC50 = 3.3 ± 0.34 µM (promastigotes), a low cytotoxicity profile (CC50 = 372.9 ± 0.04 µM), and a high selectivity index (SI = 112.6). Furthermore, 4f induced several morphological and ultrastructural changes in the free promastigote forms, loss of plasma membrane integrity, and increased reactive oxygen species (ROS). An in silico analysis of drug-likeness and ADME parameters suggested high oral bioavailability and intestinal absorption. Compound 4f reduced the number of infected macrophages and the number of amastigotes per macrophage, with an IC50 value of 18.5 ± 1.19 µM. Molecular docking studies with targets, ARG and TR, showed that compound 4f had more hydrogen bond interactions with the ARG enzyme, indicating a more stable protein-ligand binding. These results suggest that 4,8- dimethoxynaphthalenyl chalcones are worthy of further study as potential antileishmanial drugsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/56069/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALantibiotics-11-01402ok.pdfantibiotics-11-01402ok.pdfapplication/pdf7173006https://www.arca.fiocruz.br/bitstream/icict/56069/2/antibiotics-11-01402ok.pdf7f5a3bd1978183aeac7e9a1f03c10fe4MD52icict/560692022-12-19 13:12:11.532oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-12-19T16:12:11Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
title Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
spellingShingle Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
Santiago-Silva, Kaio Maciel de
4,8-dimethoxynaphthalenyl
Leishmaniasis
Neglected Diseases
Trypanosomatids
Trypanothione reductase
Arginasa
Enfermedades Desatendidas
Maladies négligées
Arginase
Leishmaniose
Doenças Negligenciadas
title_short Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
title_full Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
title_fullStr Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
title_full_unstemmed Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
title_sort Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis
author Santiago-Silva, Kaio Maciel de
author_facet Santiago-Silva, Kaio Maciel de
Bortoleti, Bruna Taciane da Silva
Oliveira, Laudicéa do Nascimento
Maia, Fernanda Lima de Azevedo
Castro, Joyce Cristina
Costa, Ivete Conchon
Lazarin, Danielle Bidóia
Wardell, James L.
Wardell, Solange M. S. V.
Albuquerque, Magaly Girão
Lima, Camilo Henrique da Silva
Pavanelli, Wander Rogério
Bispo, Marcelle de Lima Ferreira
Gonçalves, Raoni Schroeder B.
author_role author
author2 Bortoleti, Bruna Taciane da Silva
Oliveira, Laudicéa do Nascimento
Maia, Fernanda Lima de Azevedo
Castro, Joyce Cristina
Costa, Ivete Conchon
Lazarin, Danielle Bidóia
Wardell, James L.
Wardell, Solange M. S. V.
Albuquerque, Magaly Girão
Lima, Camilo Henrique da Silva
Pavanelli, Wander Rogério
Bispo, Marcelle de Lima Ferreira
Gonçalves, Raoni Schroeder B.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Santiago-Silva, Kaio Maciel de
Bortoleti, Bruna Taciane da Silva
Oliveira, Laudicéa do Nascimento
Maia, Fernanda Lima de Azevedo
Castro, Joyce Cristina
Costa, Ivete Conchon
Lazarin, Danielle Bidóia
Wardell, James L.
Wardell, Solange M. S. V.
Albuquerque, Magaly Girão
Lima, Camilo Henrique da Silva
Pavanelli, Wander Rogério
Bispo, Marcelle de Lima Ferreira
Gonçalves, Raoni Schroeder B.
dc.subject.other.en_US.fl_str_mv 4,8-dimethoxynaphthalenyl
topic 4,8-dimethoxynaphthalenyl
Leishmaniasis
Neglected Diseases
Trypanosomatids
Trypanothione reductase
Arginasa
Enfermedades Desatendidas
Maladies négligées
Arginase
Leishmaniose
Doenças Negligenciadas
dc.subject.en.en_US.fl_str_mv Leishmaniasis
Neglected Diseases
Trypanosomatids
Trypanothione reductase
dc.subject.es.en_US.fl_str_mv Arginasa
Enfermedades Desatendidas
dc.subject.fr.en_US.fl_str_mv Maladies négligées
dc.subject.decs.en_US.fl_str_mv Arginase
Leishmaniose
Doenças Negligenciadas
description Universidade Estadual de Londrina. Centro de Ciências Exatas. Departamento de Química. Laboratório de Síntese de Moléculas Medicinais. Londrina, PR, Brasil.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-12-19T16:12:10Z
dc.date.available.fl_str_mv 2022-12-19T16:12:10Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv SANTIAGO-SILVA, Kaio Maciel de et al. Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis. Antibiotics, v. 11, n. 1402, p. 1–23, 2022.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/56069
dc.identifier.issn.en_US.fl_str_mv 2079-6382
identifier_str_mv SANTIAGO-SILVA, Kaio Maciel de et al. Antileishmanial activity of 4,8-dimethoxynaphthalenyl chalcones on Leishmania amazonensis. Antibiotics, v. 11, n. 1402, p. 1–23, 2022.
2079-6382
url https://www.arca.fiocruz.br/handle/icict/56069
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/56069/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/56069/2/antibiotics-11-01402ok.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
7f5a3bd1978183aeac7e9a1f03c10fe4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324699008073728